Supernus Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Supernus Pharmaceuticals, Inc. (SUPN) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents0.070.250.090.200.290.350.36
Short-Term Investments0.380.180.370.140.130.000.00
Cash & Short-Term Investments0.450.250.460.340.420.350.36
Accounts Receivable0.140.140.170.150.140.090.10
Inventory0.050.080.090.090.050.030.03
Other Current Assets0.040.000.020.030.020.010.00
Total Current Assets0.690.490.730.600.630.470.49
Non-Current Assets
Property, Plant & Equipment (Net)0.010.010.040.020.060.020.00
Long-Term Investments0.000.020.090.120.350.000.00
Goodwill0.120.120.120.120.080.000.00
Intangible Assets0.520.600.700.780.360.000.00
Other Non-Current Assets0.030.040.010.050.020.020.00
Total Non-Current Assets0.680.780.971.090.870.690.48
Total Assets1.371.281.701.691.501.160.98
Current Liabilities
Accounts Payable0.000.080.010.010.010.050.15
Short-Term Debt0.010.000.410.010.010.000.00
Current Portion of Long-Term Debt0.000.000.410.010.010.000.00
Accrued Liabilities0.210.200.190.210.170.000.00
Other Current Liabilities0.050.060.080.060.060.110.00
Total Current Liabilities0.290.290.690.320.250.160.16
Non-Current Liabilities
Long-Term Debt0.030.030.040.380.380.380.33
Deferred Tax Liabilities0.000.020.050.090.040.000.00
Other Non-Current Liabilities0.010.160.040.050.050.030.03
Total Non-Current Liabilities0.040.220.130.560.640.400.36
Total Liabilities0.330.360.820.870.760.560.52
Stockholders' Equity
Common Stock0.000.000.000.000.000.000.00
Retained Earnings0.560.480.480.380.330.200.09
Accumulated Other Comprehensive Income0.000.000.000.000.010.010.00
Additional Paid-in Capital0.480.440.410.430.410.390.37
Shares Outstanding0.060.050.050.050.000.000.00
Total Stockholders' Equity1.040.920.890.820.740.600.45
Total Liabilities & Equity1.371.281.701.691.501.160.98